Canadian Oxygen Trial (COT) (COT)
2018年3月20日 更新者:McMaster University
Efficacy and Safety of Targeting Lower Arterial Oxygen Saturations to Reduce Oxygen Toxicity and Oxidative Stress in Very Preterm Infants: The Canadian Oxygen Trial (COT)
Study Question: In infants who are born at gestational ages of 23 0/7 to 27 6/7 weeks, does lowering the concentration of supplemental oxygen to target an arterial oxygen saturation by pulse oximetry (SpO2)of 85-89% compared with 91-95%, from the day of birth until the baby's first discharge home, increase the probability of survival without severe neurosensory disability to a corrected age of 18 months?
研究概览
详细说明
Most extremely preterm babies require supplemental oxygen for several weeks or even months after birth.
The goal of oxygen therapy is to achieve adequate oxygen delivery to the tissues without causing oxygen toxicity and oxidative stress.
At present, this goal is elusive in very immature infants.
Although it is standard practice in modern neonatal intensive care units to monitor arterial oxygen saturations via pulse oximetry, there is insufficient evidence to guide the choice of the upper and lower alarm limits.
A rigorous trial with long-term follow up is urgently needed and long overdue to determine whether oxygen exposure can be reduced safely in extremely preterm infants without increasing the risk of hypoxic death or disability.
研究类型
介入性
注册 (实际的)
1201
阶段
- 第三阶段
联系人和位置
本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。
学习地点
-
-
-
Beer Sheva、以色列、84101
- Soroka University Medical Center
-
Haifa、以色列、31048
- Bnai-Zion Medical Center
-
Kfar-Saba、以色列、44281
- Meir Medical Center
-
-
-
-
Alberta
-
Calgary、Alberta、加拿大、T2N 2T9
- Foothills Hospital
-
Edmonton、Alberta、加拿大、T5H 3V9
- Royal Alexandra Hospital
-
-
British Columbia
-
Vancouver、British Columbia、加拿大、V6H 3V4
- B.C. Children's Hospital
-
-
Manitoba
-
Winnipeg、Manitoba、加拿大、R3E 0L8
- St. Boniface General Hospital
-
Winnipeg、Manitoba、加拿大、R3L 0L8
- Winnipeg Health Sciences Centre
-
-
Nova Scotia
-
Halifax、Nova Scotia、加拿大、B3P 1R8
- IWK Health Centre
-
-
Ontario
-
Hamilton、Ontario、加拿大、L8N 3Z5
- McMaster University Medical Centre
-
Ottawa、Ontario、加拿大、K1H 8L1
- Children's Hospital of Eastern Ontario and Ottawa General Hospital
-
Toronto、Ontario、加拿大、M5G 1X5
- Mount Sinai Hospital
-
Toronto、Ontario、加拿大、M5S 1B2
- Sunnybrook Health Sciences Centre
-
-
Quebec
-
Montreal、Quebec、加拿大、H3A 1A1
- Royal Victoria Hospital
-
Montreal、Quebec、加拿大、H3T 1C5
- CHU Ste. Justine
-
Quebec City、Quebec、加拿大、G1L 3L5
- Centre Hospitalier Universitaire de Quebec
-
-
Saskatchewan
-
Saskatoon、Saskatchewan、加拿大、S7N 0W8
- Royal University Hospital
-
-
-
-
-
Tuebingen、德国
- University Children's Hospital
-
-
-
-
New York
-
Stony Brook、New York、美国、11794-8111
- Stony Brook University Medical Center
-
-
Pennsylvania
-
Philadelphia、Pennsylvania、美国、19104
- Hospital of the University of Pennsylvania (HUP)
-
Philadelphia、Pennsylvania、美国、19035
- Pennsylvania Hospital
-
-
-
-
-
Oulu、芬兰
- Oulu University Central Hospital
-
-
-
-
-
Buenos Aires、阿根廷
- Hospital Sanatorio de la Trinidad & Buenos Aires NICU Network
-
-
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
不超过 1天 (孩子)
接受健康志愿者
不
有资格学习的性别
全部
描述
Inclusion Criteria:
- Gestational age 23 0/7 - 27 6/7 weeks
- Postnatal age < 24 hours
Exclusion Criteria:
- Infant not considered viable (decision made not to administer effective therapies)
- Dysmorphic features or congenital malformations that adversely affect life expectancy or neurodevelopment
- Known or strongly suspected cyanotic heart disease
- Persistent pulmonary hypertension, e.g. associated with pulmonary hypoplasia
- Unlikely to be available for long-term follow-up
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:四人间
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:1
Supplemental oxygen to maintain functional arterial oxygen saturations in the range of 85-89%.
Dose of oxygen is determined by the individual infant's need to achieve the target oxygen saturations.
|
Supplemental oxygen to maintain functional arterial oxygen saturations in one of two saturation target ranges.
其他名称:
|
|
有源比较器:2
Supplemental oxygen to maintain functional arterial oxygen saturations in the range of 91-95%.
Dose of oxygen is determined by the individual infant's need to achieve the target oxygen saturations.
|
Supplemental oxygen to maintain functional arterial oxygen saturations in one of two saturation target ranges.
其他名称:
|
研究衡量的是什么?
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
Survival without severe neurosensory disability to 18 to 21 months (corrected for prematurity)
大体时间:18-21 months corrected for prematurity
|
18-21 months corrected for prematurity
|
次要结果测量
结果测量 |
大体时间 |
|---|---|
|
Retinopathy of prematurity
大体时间:32 to 44 weeks postmenstrual age
|
32 to 44 weeks postmenstrual age
|
|
Bronchopulmonary dysplasia
大体时间:36 weeks postmenstrual age
|
36 weeks postmenstrual age
|
|
Brain injury
大体时间:from week one of life up to 36 weeks postmenstrual age
|
from week one of life up to 36 weeks postmenstrual age
|
|
Patent ductus arteriosus
大体时间:until first discharge home
|
until first discharge home
|
|
Necrotizing enterocolitis
大体时间:until first discharge home
|
until first discharge home
|
|
Growth
大体时间:until 18-21 months corrected for prematurity
|
until 18-21 months corrected for prematurity
|
|
respiratory morbidity
大体时间:until 18-21 months corrected for prematurity
|
until 18-21 months corrected for prematurity
|
|
Mean developmental index scores on the Bayley Scales
大体时间:18-21 months corrected for prematurity
|
18-21 months corrected for prematurity
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
调查人员
- 学习椅:Barbara Schmidt, MD、McMaster University
- 首席研究员:Robin Roberts, MMath、Hamilton Health Sciences/McMaster University
- 首席研究员:Elizabeth Asztalos, MD、Sunnybrook Health Sciences Centre
- 首席研究员:Alfonso Solimano, MD、Children's & Women's Health Centre of BC
- 首席研究员:Robin Whyte, MD、IWK Health Centre
- 首席研究员:Jack Rabi, MD、Foothills Hospital
- 首席研究员:Christian Poets, MD、University Children's Hospital Tuebingen
出版物和有用的链接
负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。
一般刊物
- Schmidt B, Whyte RK, Asztalos EV, Moddemann D, Poets C, Rabi Y, Solimano A, Roberts RS; Canadian Oxygen Trial (COT) Group. Effects of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants: a randomized clinical trial. JAMA. 2013 May 22;309(20):2111-20. doi: 10.1001/jama.2013.5555.
- Schmidt B, Roberts RS, Whyte RK, Asztalos EV, Poets C, Rabi Y, Solimano A, Nelson H; Canadian Oxygen Trial Group. Impact of study oximeter masking algorithm on titration of oxygen therapy in the Canadian oxygen trial. J Pediatr. 2014 Oct;165(4):666-71.e2. doi: 10.1016/j.jpeds.2014.05.028. Epub 2014 Jun 25.
- Jensen EA, Whyte RK, Schmidt B, Bassler D, Vain NE, Roberts RS; Canadian Oxygen Trial Investigators. Association between Intermittent Hypoxemia and Severe Bronchopulmonary Dysplasia in Preterm Infants. Am J Respir Crit Care Med. 2021 Nov 15;204(10):1192-1199. doi: 10.1164/rccm.202105-1150OC.
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始
2006年12月1日
初级完成 (实际的)
2012年9月1日
研究完成 (实际的)
2012年12月1日
研究注册日期
首次提交
2008年3月6日
首先提交符合 QC 标准的
2008年3月10日
首次发布 (估计)
2008年3月17日
研究记录更新
最后更新发布 (实际的)
2018年3月22日
上次提交的符合 QC 标准的更新
2018年3月20日
最后验证
2014年12月1日
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.